EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Curcumin and Cancer-Related Inflammation

Kaitlyn LeBlanc iD, Emilee Brewer iD, Sita Aggarwal iD

Nutrients · 21.05.2026 · 18 (10) · 1636

DOI: 10.3390/nu18101636 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 21.05.2026. Verfasst von Kaitlyn LeBlanc und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Prevention Laboratory, Southeastern Louisiana University, Hammond, LA 70403, USA. Hauptthemen laut MEDLINE: Curcumin, Inflammation, Neoplasms, Anti-Inflammatory Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic inflammation is a well-established risk factor for cancer progression. This review aims to determine how persistent inflammatory signaling reshapes the tissue microenvironment to favor tumor cell proliferation, survival, and progression. It also discusses the role of cytokines such as IL-6 and TGF-β, reactive oxygen species (ROS), and the transcription factors NF-κB and STAT3 in inflammation and in the tumor microenvironment. Sustained activation of these pathways promotes genomic instability, loss of tumor suppressor gene function, enhanced oncogene expression, and resistance to apoptosis, collectively facilitating malignant transformation and tumor development. The key novelty of this review lies in integrating these interconnected networks with new evidence to clarify how they drive cancer initiation and progression. Furthermore, we discuss the therapeutic potential of plant-derived bioactive compounds, with a particular emphasis on curcumin. Curcumin exhibits significant anti-inflammatory and anticancer effects through inhibition of NF-κB and STAT3 signaling and its downstream targets, thereby attenuating inflammation-driven tumorigenesis. However, its clinical application is limited by poor bioavailability. Finally, this review highlights current strategies to overcome these limitations and future directions for optimizing curcumin-based interventions in inflammation-associated diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminInflammationNeoplasmsAnti-Inflammatory AgentsHumansSignal TransductionAnimalsSTAT3 Transcription FactorTumor MicroenvironmentNF-kappa BReactive Oxygen SpeciesCytokines

Stichwörter der Autor:innen

curcumincytokinesinflammationnuclear transcription factor–kappa Breactive oxygen speciessignal transducer and activator of transcription 3

Substanzen

CurcuminSTAT3 Transcription FactorAnti-Inflammatory AgentsNF-kappa BReactive Oxygen SpeciesCytokines

Autor:innen und Institutionen

  • Cancer Prevention Laboratory, Southeastern Louisiana University, Hammond, LA 70403, USA.

ORCID-Profile: Kaitlyn LeBlanc, Emilee Brewer, Sita Aggarwal

Zitieren

APA

LeBlanc, K., Brewer, E., & Aggarwal, S. (2026). Curcumin and Cancer-Related Inflammation. Nutrients, 18(10), 1636. https://doi.org/10.3390/nu18101636

Vancouver

LeBlanc K, Brewer E, Aggarwal S. Curcumin and Cancer-Related Inflammation. Nutrients. 2026;18(10):1636. doi:10.3390/nu18101636

BibTeX
@article{LeBlanc2026,
  author = {LeBlanc, Kaitlyn and Brewer, Emilee and Aggarwal, Sita},
  title = {Curcumin and Cancer-Related Inflammation},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {10},
  pages = {1636},
  doi = {10.3390/nu18101636}
}
Kostenlos starten →